Stockreport

Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares

Centessa Pharmaceuticals plc - American Depositary Shares  (CNTA) 
PDF BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and de [Read more]